First U.S. Monkeypox Death Reported in Texas
TUESDAY, Aug. 30, 2022 (HealthDay News) -- A Texas patient who was infected with monkeypox has died, though state health officials said Tuesday it is too early to say what role the virus may have played in the death.
The adult, who died in a hospital in Harris County, was "severely immunocompromised" and had "various severe illnesses," health officials said. Autopsy results are expected in the next few weeks.
"Monkeypox is a serious disease, particularly for those with weakened immune systems," Texas Department of Health Services Commissioner John Hellerstedt, M.D, said in a news release announcing the death. "We continue to urge people to seek treatment if they have been exposed to monkeypox or have symptoms consistent with the disease."
"We are sharing this information to err on the side of transparency and to avoid potential misinformation about this case," Harris County Judge Lina Hidalgo said in a separate statement. "The best way for us to fight this virus is through vaccines. Our goal is still to get as many people who qualify vaccinated as quickly as possible -- I have always felt that vaccines are the key to reducing spread."
The death is the first in the United States publicly reported in a person who had monkeypox. Texas has had 1,604 reported monkeypox infections during the current outbreak, which started in the spring. There are now more than 18,000 cases confirmed across the United States, according to figures from the U.S. Centers for Disease Control and Prevention.
Related Posts
Estas fiestas de fin de año, mantenga la intoxicación alimentaria a raya
MARTES, 22 de noviembre de 2022 (HealthDay News) -- Un feliz día de fiesta puede...
Feds Warn of Home Carbon Monoxide Detectors That May Fail to Alarm
THURSDAY, Sept. 22, 2022 (HealthDay News) -- Consumers should immediately stop...
RSVpreF Safe, Effective for Preventing Respiratory Syncytial Virus Illness in Seniors
MONDAY, April 10, 2023 (HealthDay News) -- The respiratory syncytial virus...
Benefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer
MONDAY, March 13, 2023 (HealthDay News) -- For patients with advanced renal cell...